HO CAROLE (Chief Medical Officer) sold 1.7% of their position (3.74K shares) of DENALI THERAPEUTICS INC. on the open market
Open‑market sale worth $51.7K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 8/14/2025ACC: 0001714899-25-000176
Officer· Chief Medical Officer
Since Aug 2018
-3.74K
Net shares
Net seller
$51.7K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
3.74K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−2.94K
Price / share
$13.58
Trade value
$39.88K
% of position
1.3%
8/12/2025
220.33K→217.39K
Common Stock
Direct
Shares
−806.00
Price / share
$14.64
Trade value
$11.80K
% of position
0.4%
8/13/2025
217.39K→216.59K
Total
Net shares
−3.74K
Net value
-$51.68K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/12/2025 | S · Sale | −2.94K | $13.58 | $39.88K | 1.3% | 220.33K | 217.39K |
| Common Stock Direct | 8/13/2025 | S · Sale | −806.00 | $14.64 | $11.80K | 0.4% | 217.39K | 216.59K |
| Total | −3.74K | -$51.68K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned25K
Common Stock
IndirectShares owned183.22K
Total
208.22K indirect208.22K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 25K | Indirect |
| Common Stock | 183.22K | Indirect |
| Total | 208.22K | 208.22K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported